Preoperative peripheral blood neutrophil count predicts long-term outcomes following hepatic resection for colorectal liver metastases

Haruki,Koichiro; Shiba,Hiroaki; Fujiwara,Yuki; Furukawa,Kenei; Iida,Tomonori; Ohkuma,Masahisa; Ogawa,Masaichi; Ishida,Yuichi; Misawa,Takeyuki; Yanaga,Katsuhiko

doi:10.3892/ol.2017.5873

Preoperative peripheral blood neutrophil count predicts long-term outcomes following hepatic resection for colorectal liver metastases

Authors:
- Koichiro Haruki
- Hiroaki Shiba
- Yuki Fujiwara
- Kenei Furukawa
- Tomonori Iida
- Masahisa Ohkuma
- Masaichi Ogawa
- Yuichi Ishida
- Takeyuki Misawa
- Katsuhiko Yanaga
View Affiliations

Affiliations: Department of Surgery, The Jikei University School of Medicine, Tokyo 105‑8461, Japan
Published online on: March 17, 2017 https://doi.org/10.3892/ol.2017.5873
Pages: 3688-3694

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Preoperative systemic inflammatory response is associated with a poor long-term prognosis following resection surgery for malignant tumors. Several markers of systemic inflammation have been reported to be associated with the outcome; however, they have not currently been fully investigated. Therefore, the association between preoperative peripheral blood neutrophil count and oncological outcome following hepatic resection for colorectal liver metastasis (CRLM) was retrospectively investigated. The present study comprised 89 patients who had undergone hepatic resection for CRLM between January 2000 and March 2010. The association between preoperative peripheral blood neutrophil count and disease‑free survival, in addition to overall survival, was investigated. In multivariate analysis, the presence of neoadjuvant chemotherapy (P=0.015), bilobar distribution (P=0.015) and neutrophil count ≥3,500/µl (P=0.025) were independent and significant predictors of poor disease‑free survival, while significant predictors of poor overall survival consisted of >4 lymph node metastases (P=0.001), neo‑adjuvant chemotherapy (P=0.003), bilobar distribution (P=0.039) and neutrophil count ≥3,500/µl (P=0.040). Additionally, tumor diameter (P=0.021) and monocyte count (P<0.0001) were observed to be significantly greater in the elevated neutrophil count group. In conclusion, preoperative peripheral blood neutrophil count may be an independent and significant indicator of poor long‑term outcomes in patients with CRLM following hepatic resection.

View Figures

View References

1	O'Reilly DA and Poston GJ: Colorectal liver metastases: Current and future perspectives. Future Oncol. 2:525–531. 2006. View Article : Google Scholar : PubMed/NCBI
2	Fong Y, Fortner J, Sun RL, Brennan MF and Blumgart LH: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg. 230:309–321. 1999. View Article : Google Scholar : PubMed/NCBI
3	Malik HZ, Prasad KR, Halazun KJ, Aldoori A, Al-Mukhtar A, Gomez D, Lodge JP and Toogood GJ: Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg. 246:806–814. 2007. View Article : Google Scholar : PubMed/NCBI
4	Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ and Rees M: Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies. Br J Cancer. 94:982–999. 2006. View Article : Google Scholar : PubMed/NCBI
5	Loupakis F, Cremolini C, Masi G, Lonardi S, Zagonel V, Salvatore L, Cortesi E, Tomasello G, Ronzoni M, Spadi R, et al: Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer. N Engl J Med. 371:1609–1618. 2014. View Article : Google Scholar : PubMed/NCBI
6	Simkens LH, van Tinteren H, May A, ten Tije AJ, Creemers GJ, Loosveld OJ, de Jongh FE, Erdkamp FL, Erjavec Z, van der Torren AM, et al: Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): A phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group. Lancet. 385:1843–1852. 2015. View Article : Google Scholar : PubMed/NCBI
7	Proctor MJ, Morrison DS, Talwar D, Balmer SM, O'Reilly DS, Foulis AK, Horgan PG and McMillan DC: An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumor site: A Glasow inflammation outcome study. Br J Cancer. 104:726–734. 2011. View Article : Google Scholar : PubMed/NCBI
8	McMillan DC: An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc. 67:257–262. 2008. View Article : Google Scholar : PubMed/NCBI
9	Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, Toogood GJ and Lodge JP: Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol. 34:55–60. 2008. View Article : Google Scholar : PubMed/NCBI
10	Giakoustidis A, Neofytou K, Khan AZ and Mudan S: Neutrophil to lymphocyte ratio predicts pattern of recurrence in patients undergoing liver resection for colorectal liver metastasis and thus the overall survival. J Surg Oncol. 111:445–450. 2015. View Article : Google Scholar : PubMed/NCBI
11	Gomez D, Morris-Stiff G, Wyatt J, Toogood GJ, Lodge JP and Prasad KR: Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis. J Surg Oncol. 98:371–376. 2008. View Article : Google Scholar : PubMed/NCBI
12	Mano Y, Shirabe K, Yamashita Y, Harimoto N, Tsujita E, Takeishi K, Aishima S, Ikegami T, Yoshizumi T, Yamanaka T and Maehara Y: Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: A retrospective analysis. Ann Surg. 258:301–305. 2013. View Article : Google Scholar : PubMed/NCBI
13	Fujiwara Y, Shiba H, Furukawa K, Iida T, Haruki K, Gocho T, Wakiyama S, Hirohara S, Ishida Y, Misawa T, et al: Glasgow prognostic score is related to blood transfusion requirements and post-operative complications in hepatic resection for hepatocellular carcinoma. Anticancer Res. 30:5129–5136. 2010.PubMed/NCBI
14	Haruki K, Shiba H, Fujiwara Y, Furukawa K, Wakiyama S, Ogawa M, Ishida Y, Misawa T and Yanaga K: Negative impact of surgical site infection on long-term outcomes after hepatic resection for colorectal liver metastases. Anticancer Res. 33:1697–1703. 2013.PubMed/NCBI
15	Fujiwara Y, Shiba H, Furukawa K, Iida T, Sakamoto T, Gocho T, Wakiyama S, Hirohara S, Ishida Y, Misawa T, et al: Perioperative change in white blood cell count predicts outcome of hepatic resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 17:892–897. 2010. View Article : Google Scholar : PubMed/NCBI
16	Shiba H, Furukawa K, Fujiwara Y, Futagawa Y, Haruki K, Wakiyama S, Ishida Y, Misawa T and Yanaga K: Postoperative peak serum C-reactive protein predicts outcome of hepatic resection for hepatocellular carcinoma. Anticancer Res. 33:705–709. 2013.PubMed/NCBI
17	Haruki K, Shiba H, Fujiwara Y, Furukawa K, Wakiyama S, Ogawa M, Ishida Y, Misawa T and Yanaga K: Perioperative change in peripheral blood monocyte count may predict prognosis in patients with colorectal liver metastasis after hepatic resection. J Surg Oncol. 106:31–35. 2012. View Article : Google Scholar : PubMed/NCBI
18	Miyagawa S, Makuuchi M, Kawasaki S and Kakazu T: Criteria for safe hepatic resection. Am J Surg. 169:589–594. 1995. View Article : Google Scholar : PubMed/NCBI
19	Strasberg SM: Nomenclature of hepatic anatomy and resections: A review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg. 12:351–355. 2005. View Article : Google Scholar : PubMed/NCBI
20	Coussens LM and Werb Z: Inflammation and cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
21	Jaiswal M, LaRusso NF, Burgart LJ and Gores GJ: Inflammatory cytokines induce DNA repair in cholangiocarcinoma cells by a nitricoxide-dependent mechanism. Cancer Res. 60:184–190. 2000.PubMed/NCBI
22	McMillan DC, Canna K and McArdle CS: Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg. 90:215–219. 2003. View Article : Google Scholar : PubMed/NCBI
23	Kobayashi T, Teruya M, Kishiki T, Endo D, Takenaka Y, Miki K, Kobayashi K and Morita K: Elevated C-reactive protein and hypoalbuminemia measured before resection of colorectal live rmetastases predict postoperative survival. Dig Surg. 27:285–290. 2010. View Article : Google Scholar : PubMed/NCBI
24	Neal CP, Mann CD, Garcea G, Briggs CD, Dennison AR and Berry DP: Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases. Arch Surg. 146:471–478. 2011. View Article : Google Scholar : PubMed/NCBI
25	Grivennikov SI, Greten FR and Karin M: Immunity, inflammation, and cancer. Cell. 140:883–899. 2010. View Article : Google Scholar : PubMed/NCBI
26	Taichman NS, Young S, Cruchley AT, Taylor P and Paleolog E: Human neutrophils secrete vascular endothelial growth factor. J Leukoc Biol. 62:397–400. 1997.PubMed/NCBI
27	Maniwa Y, Okada M, Ishii N and Kiyooka K: Vascular endothelial growth factor increased by pulmonary surgery accelerates the growth of micrometastases in metastatic lung cancer. Chest. 114:1668–1675. 1998. View Article : Google Scholar : PubMed/NCBI
28	Farid SG, Aldouri A, Morris-Stiff G, Khan AZ, Toogood GJ, Lodge JP and Prasad KR: Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. Ann Surg. 251:91–100. 2010. View Article : Google Scholar : PubMed/NCBI
29	Nakano H, Oussoultzoglou E, Rosso E, Casnedi S, Chenard-Neu MP, Dufour P, Bachellier P and Jaeck D: Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg. 247:118–124. 2008. View Article : Google Scholar : PubMed/NCBI
30	Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, et al: Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 24:2065–2072. 2006. View Article : Google Scholar : PubMed/NCBI
31	Viganò L, Capussotti L, De Rosa G, De Saussure WO, Mentha G and Rubbia-Brandt L: Liver resection for colorectal metastases after chemotherapy: Impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival. Ann Surg. 258:731–742. 2013. View Article : Google Scholar : PubMed/NCBI
32	Leal JN, Bressan AK, Vachharajani N, Gonen M, Kingham TP, D'Angelica MI, Allen PJ, DeMatteo RP, Doyle MB, Bathe OF, et al: Time-to-surgery and survival outcomes in resectable colorectal liver metastases: A multi-institutional evaluation. J Am Coll Surg. 222:766–779. 2016. View Article : Google Scholar : PubMed/NCBI
33	Balkwill F and Mantovani A: Cancer and inflammation: Implications for pharmacology and therapeutics. Clin Pharmacol Ther. 87:401–406. 2010. View Article : Google Scholar : PubMed/NCBI